Wheeler Craig A

Wheeler Craig A is listed in filings as Director at Apellis Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 14, 2026, including 20 public disclosures. Recent filings connect the profile to Apellis Pharmaceuticals, Inc. (APLS) and AMICUS THERAPEUTICS INC (FOLD). The current snapshot covers public activity from Apr 21, 2025 to May 14, 2026. Reported amounts are shown as $513.1K to $97.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.